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The effect of corticosteroids on the developing nervous system 
was investigated using Sprague-Dawley rats. Administration of 
methylprednisolone during the neonatal period resulted in a significant 
retardation in myelination of the pyramidal tracts, and a decrease in 
proliferation of dendrites in the parietal cortex. Specifically, the 
following findings emerged: 
(1) a decrease in frequency of myelinated fibers; 
(2) a decrease in mean number of lamellae; 
(3) a decrease in number of lamellae for a given axon 
circumference; 
(4) a decrease in the number of dendrites intersecting, branching, 
and ending at distances farther from the perikaryon. 
These data suggest that early corticosteroid administration inhibits 
myelination and dendritic formation in the rat. 
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In recent years, corticosteroids have been used with increasing 
frequency in the treatment of a variety of diseases in infancy and 
childhood as well as in pregnant women (Klevit, 1970). For example, 
steroids have been used as anti-inflammatory and immunosuppressive 
agents in such common disorders as asthma and allergic syndromes 
(Foley, et al., 1957; Fischel, et al., 1958; Knowles, 1961; Liddle, 
1961; Hitchings 8 Elion, 1963). They have been administered, also, 
in less common conditions such as the nephrotic syndrome (Barnett, 
et al., 1952; Boland, 1952; Riley, 1952). Most recently they have 
been used in the treatment of respiratory distress syndrome of infancy 
(Avery, 1972; Baden et al., 1972; Liggins 8 Howie, 1972). 
Aside from their retarding effects on growth (Blodgett, 1956; 
Van Metre 8 Pinkerton, 1959; Falliers et al., 1963; Morris et al., 
1968a, 1968b), little is known about the long term side effects on 
development of chronic steroid administration in infants or pregnant 
women (Bank et al., 1960; Kreines et al., 1964; Yackel et al., 1966; 
Warrell 8 Taylor, 1968; Schwartz, 1971). This is particularly true 
with respect to their effect on the developing nervous system. 
Recently, De Lemos and Haggerty (1969) have reported an increase 
in long-term residual neurological deficits following bacterial 
meningitis in infants and children treated with methylprednisone as 
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compared with non-steroid treated patients. Recent clinical experience 
at Yale-New Haven Hospital, to be described later in this thesis, has 
suggested, also, that neurological sequelae may result from chronic 
steroid therapy in infancy. 
In animals, experimental neonatal corticosteroid treatment has 
been shown to cause an irreversible reduction in brain weight (Howard, 
1965). As will be described below in detail, other studies in animals 
have indicated definite biochemical and electrophysiological alterations 
in the developing brain as a result of steroid administration during 
the neonatal period. 
To date, however, there have been almost no reported studies 
indicating whether steroids can cause distinct morphological changes 
in individual neurons of a developing nervous system. In particular, 
there have been no reported studies on the effect of steroids in neo¬ 
natal animals on the myelination of axons nor on the formation of 
dendritic processes. In humans and certain other species, it is known 
that both myelination and dendritic formation continue well into the 
postnatal period (Dobbing, 1968a). Because certain conditions such as 
hypothyroidism (Eayrs, 1955; Horn, 1955; Balazs et al., 1971; Hamburgh 
et al., 1971; Nicholson 8 Altman, 1972; Rosman et al., 1972; Bass 
et al., 1973), anoxia (Hicks, Cavanaugh 8 O'Brien, 1962), x-irradiation 
(Hicks, D'Amato 8 Lowe, 1959; Hicks, D'Amato 8 Falk, 1962; Hicks 8 
D'Amato, 1963; D'Amato 8 Hicks, 1965; Dobbing et al, 1970c), and 
malnutrition during this postnatal period (Donaldson, 1911; Dobbing, 
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1964; Dobbing, 1965; Benton, 1966; Winick and Noble, 1966; Culley 
and Lineberger, 1969; Bass et. al., 1970; Winick, 1970; Cragg, 1972; 
Patel et. al., 1973) can cause permanent alterations in neuronal 
structure in animals, it is possible that steroid administration 
might also affect the structure of developing neurons. Accordingly, 
this thesis was designed to examine possible specific structural 
changes in the brains of rats when treated neonatally with steroids. 
In particular, this study shows that the myelination of axons and the 
proliferation of dendritic processes are significantly altered following 
a single injection of steroid during the neonatal period. 
-3- 
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II. BACKGROUND 
Administration of corticosteroids to neonatal experimental 
animals produces a "wasting syndrome" characterized by marked weight 
loss, ruggled fur, and, often, death (Field, 1954; Field, 1955; 
Schlesinger 8 Mark, 1964; Howard, 1965; Schapiro, 1965; Schapiro 
^ Huppert, 1967; Schapiro, 1968) . Such steroid treatment has been 
shown, also, to exert a permanent adverse effect on the central nervous 
system (Field, 1955; Howard, 1968b; Schapiro, 1968; Salas 8 Schapiro, 
1970; Schapiro et al., 1970; Schapiro, 1971). 
As early as 1954, for example, it was demonstrated that cortisone 
acetate in doses of 0.25 - 0.5 mg/day over a one to three day period 
beginning shortly after birth causes a suppression of microglial 
migration and transformation in the brain (Field, 1954; Field, 1955). 
More recently, quantitative neurochemical measurements have shown that 
steroids decrease the number of nerve cells present as well as the total 
amount of myelin lipids. Thus, Howard (1965) measured the amount of 
DNA present in control and steroid-treated neonatal mouse brains, as 
well as the RNA/DNA ratio and the cholesterol/DNA ratio in order to 
determine cell size, cell number, and degree of myelination. She found 
that subcutaneously implanted corticosterone (producing doses of 0.08 
to 0.6 mg/day between two and seven days of age) resulted, by 17 days 
of age, in a decrease in total DNA, the RNA/DNA ratio, and the cholesterol/ 
DNA ratio in the mouse cerebrum and cerebellum. Follow-up studies in 
-4- 

adult mice (350 days) similarly treated during the neonatal period 
(Howard, 1968b) showed a continuing decrease in total DNA and in the 
cholesterol/DNA ratio but no significant decrease in the RNA/DNA ratio. 
Subsequently, Cotterrell, Balazs, and Johnson (1972) studied this 
reduction in cell number by labeling techniques. Injection of cortisol 
acetate, 0.2 mg/day intraperitoneally during the first four postnatal 
days in rats resulted in a strong inhibition of incorporation of 
14 
[2- C]-thymidine into brain DNA in the treated group. On the basis 
of these experiments, they confirmed the demonstration by Howard of a 
decrease in cellularity, and, furthermore, attributed this reduction 
to a decrease in cell division as opposed to an increase in cell 
destruction. 
Behavioral experiments have shown that steroids can cause long¬ 
term functional deficits in animals. Following a single injection of 
1 mg cortisol acetate on the day of birth, Sprague-Dawley rats exhibit 
decreased spontaneous exploratory locomotor activity (Schapiro, 1968). 
Similarly, Howard and Granoff (1968) have shown that mice treated as 
described above in their neurochemical experiments, initially exhibit 
an increased voluntary running in activity wheels but a decreased 
activity in exploration in an open field. In addition, the treated 
mice tend to show a poorer initial adjustment to mazes, suggestive of 
emotional lability. 
Finally, physiological changes due to neonatal steroid administrat¬ 
ion have been investigated. In the rat, a retardation in the development 
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of evoked cortical responses to visual, auditory, and sciatic nerve 
stimulation has been demonstrated (Salas £ Schapiro, 1970; Schapiro, 
1971). The sequence of evoked cortical potential development, which 
progresses from the somesthetic area to the auditory, and finally to 
the visual area, is in agreement with anatomical studies which demon¬ 
strate that myelinization follows a similar sequential course, appearing 
first in the motor area, then proceeding to the somesthetic, auditory, 
and visual cortices, respectively (Grossman, 1955; Jacobson, 1963; 
Rose, 1968; Rose $ Ellingson, 1970). Finally, it was demonstrated 
that neonatal cortisol treatment delays the maturation of swimming 
ability in rats, and that this delay corresponds to ontogenetic shifts 
in the characteristics of the evoked potential described above (Schapiro 
et al., 1970) . 
Although the above neurochemical, behavioral, and physiological 
studies suggest, indirectly, that steroids may interfere with the 
normal myelination and dendritic development of nerve cells, they 
supply no direct evidence for steroid-induced morphological changes in 
neurons. 
The following experimental sections of this thesis present data 
which confirm the hypothesis that neonatally administered steroids 




A. CASE REPORT 
The present study was prompted by the observation of a wasting 
syndrome with microcephaly in a human infant who had been treated 
during the first year of life with large doses of corticosteroids. 
R.V., a two year old white male, was first evaluated at Yale- 
New Haven Hospital at 14 months of age because of failure to thrive 
and progressive weakness of six months' duration. He was the youngest 
of three children and was the product of a normal full-term pregnancy 
and delivery. At three months of age, he developed a transient facial 
rash which was diagnosed as eczema. At four months of age, fruits 
were introduced and led to vomiting. Because of these difficulties, 
as well as multiple food allergies in the siblings, he was maintained 
on breast milk alone until eight months of age and during this period 
grew well (Figure 1). His feedings were then changed to Neomulsoy and 
concurrently, Kenalog 1 cc (40 mg Triamcinolone = 500 mg cortisone) intra¬ 
muscularly every two weeks was begun. Shortly thereafter, bowel movements 
increased to six per day, growth ceased (Figure 1) and weakness developed. 
The steroids were discontinued at 12 months of age, but the growth arrest 
persisted. 
The family history was negative for endocrine and neurologic 
diseases. Two older siblings had multiple food allergies. The parents 
and siblings were of average stature and there was no known consanguinity. 
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At 14 months of age, the patient presented as an alert infant 
with a pleasant disposition. He was strikingly small, with a weight 
of 6800 grams, height of 68 cm, and a head circumference of 44 cm 
(all below the third percentile) (Figure 1). There was marked muscle 
wasting, especially proximally. The face was full and plethoric. The 
forehead was hirsute, and there was a nuchal fat pad. Examination of 
the chest, abdomen, and genitalia was unremarkable. On neurologic 
examination there was mild proximal muscle weakness with inability to 
pull to a stand but ability to take a few steps holding on once he was 
placed in a standing position. The muscle tone was somewhat decreased. 
The deep tendon reflexes were normal, and there were no pathologic 
reflexes. Fine motor coordination in the fingers was good. He had bi¬ 
lateral pincer grasp and transferred objects readily. He would not, 
however, search for hidden objects, and he had no speech. Cranial nerve 
and sensory examinations were normal. 
Laboratory data two months after steroid withdrawal revealed 
normal values for complete blood count, BUN, serum electrolytes, protein 
bound iodine, thyroxine, and growth hormone. Serum carotene was initially 
low but rose to normal levels after refeeding with yellow vegetables. 
Stool fat was normal, and the stools were positive for trypsin. A sweat 
test was normal. A 24-hour urine contained 0.3 mg of 17 keto-steroids 
(normal 0 to 5 mg) and less than 0.1 of 17-hydroxycorticoids (normal = 1 mg). 
Morning plasma 11-hydroxycorticoid levels were 3 and 5 pg% (normal 12-24 pg%), 
and rose to 34 /)ug% (normal response) after three days of ACTH stimulation. 
The bone age was retarded to six months. 
-8- 
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FIGURE 1 
AGE ( months) 
AGE (months) 
R.V.'s weight, length, and head circumference growth charts. Body growth 
was well within normal limits until steroids were introduced at which point 
linear growth ceased and did not resume until 7 months following cessation 
of steroid treatment. The weight gain continued during the initial 2 months 
of steroid treatment but then fell. The head circumference was normal at 
birth but clearly well below the 3rd percentile when the child presented to 
YNHH. With cessation of steroid treatment, the weight has recovered somewhat 




At 19 months of age (seven months after steroid withdrawal), 
growth began and has persisted to the present age of 24 months. Various 
diet changes and a trial on Diodoquin have not altered the bowel pattern 
and have not correlated with the growth rate. The eczematous facial 
rash has reappeared and has fluctuated with dietary manipulation. By 
17 months of age, a spot morning plasma 11-hydroxycorticoid level had 
risen to 24 pg%. By the age of 24 months, the bone age had increased 
to 12 months. Development has been slow with acquisition of independent 
walking at 20 months and absence of speech at the present age of 24 
months. 
B. MATERIALS AND METHODS 
1. Myelination 
Eighteen Sprague-Dawley rats (Group lb) from three litters were 
given a single intramuscular injection of 0.02 ml methylprednisolone 
(Depo-Medrol, 40 mg/ml, Upjohn) six days postnatally. Controls 
(Group la) were littermates injected intramuscularly with 0.02 ml 
sterile saline (0.9% NaCl, McGaw Laboratories, Inc.). Seven steroid 
treated rats survived, and of these, five were sacrificed at 21+^ 1 days 
(3 weeks) and two at 41+_1 days (6 weeks) . Rats were anesthetized 
with sodium pentobarbital (30 mg/kg) intraperitoneally, and the tissues 
were fixed by means of intravascular perfusion with 4.2% glutaraldehyde 
in phosphate buffer (pH 7.2) at 37°C. Perfusion was continued for at 
least five minutes. The rats were then decapitated and the fixed 
brains immediately removed and weighed. Olfactory bulbs were not 
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included. Blocks were taken from the pyramidal tracts on the ventral 
surface of the medulla oblongata at the level of the inferior olivary 
nuclei. 
The blocks were washed overnight in buffer, fixed further in 
1% osmium tetroxide for two hours, dehydrated in the usual manner, 
and embedded in maraglas. Thick (one micron) sections were cut, 
stained with toluidine blue, and viewed with a light microscope for 
orientation purposes. 500A thin sections were cut on an LKB Ultratome, 
mounted on unsupported 200 mesh copper grids, and counterstained 
with uranyl acetate. All thin sections were examined with an RCA 
EMU-3F electron microscope. Ten electron micrographs were taken 
randomly of each animal's pyramidal tracts at a primary magnification 
of 32,000. Fiber counts were made of three randomly selected fields 
for each rat. 
Myelination was evaluated using the criteria of Samorajski 
and Friede (1968): (1) fiber density: the percentage of myelinated 
fibers to the total number of fibers per unit area; (2) fiber 
spectrum: the frequency of various fiber groups (in terms of number 
of lamellae); and (3) the relationship of axon circumference to the 
number of lamellae in the sheath. Axon circumference was measured 
with K and E map measure (1 map meter unit - 0.25 jj) . 
2. Dendritic Development 
Sprague-Dawley rats from three litters were divided into 
four groups and given a single intramuscular dose of steroid or 
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saline as follows: 
Group Ha (Control) (14 rats): 0.02 ml sterile saline, 6 days 
postnatally 
Group lib (21 rats): 0.02 ml methylprednisolone, 6 days postnatally 
Group lie (4 rats): 0.02 ml methy lprednisolone, 9 days postnatally 
Group 11d (4 rats): 0.02 ml methylprednisolone, 11 days postnatally 
Of the steroid-treated rats, nine in Group lib, four in Group lie, 
and four in Group lid survived, and were sacrificed by decapitation as 
follows: 
Group I la: 7 rats sacrificed at 21 days (3 weeks) 
7 rats sacri ficed at 42 days (6 weeks) 
Group lib: 5 rats sacri ficed at 21 days 
4 rats sacrifi ced at 42 days 
Group lie: 2 rats sacrificed at 21 days 
2 rats sacrificed at 42 days 
Group lid: 2 rats sacri fi ced at 21 days 
2 rats sacrificed at 42 days 
Rats were decapitated by means of a guillotine. Brains were 
immediately removed and weighed. Olfactory bulbs were not included. 
Frontal sections, approximately 2 mm in width were taken from the 
parietal cortex and were placed into freshly prepared Golgi-Cox 
fixative, consisting of a mixture of the following: K^CryOy, 10 gm 
in 450 ml distilled water; Hg Cl9, 10 gm in 450 ml distilled water; 
and KyCrO^, 3 gm in 100 ml distilled water. The tissues were incubated 
in the fixative solution for 6-8 weeks at 37°C. They were then de¬ 
hydrated and embedded in celloidin and cut into 90 p. sections. These 
-12- 

cut sections were exposed to 1% aqueous NH^OH for about 20 seconds 
and were then dehydrated and mounted on glass slides. 
Measurement of Dendrites 
a. Selection of Cells 
Quantitative analysis was carried out on pyramidal cells 
from layer 3 and layer 5 of the parietal cortex. Fifteen to forty 
cells from each layer were selected randomly according to the 
following criteria: (1) cells were chosen from regions in which 
there was relatively little superimposition of cell bodies and 
branchings from neighboring neurons, and (2) regions were selected 
in which breakage of dendrites was minimal. Pyramidal cells thus 
selected for analysis were drawn by tracing the projected outline 
of the cell and its dendrites on paper using a Leitz microscope 
with drawing attachment. 
b. Method of Measurement 
The image of each neuronal perikaryon was projected onto the 
center of a target, and all dendrites extending from the perikayron 
were drawn on a grid of fifteen concentrically arranged zones, each 
of a width which represented a distance of 18 ju in the histological 
section. The following measurements were made (Eayrs, 1955; Eayrs 
and Goodhead, 1959; Schade and Van Groenigen, 1969): 
(1) the number of dendrites arising from the perikaryal 
surface (basal dendrites) 
(2) the number of dendrites intersecting the zonal boundaries 
at successive distances of 18 ju from the cell body 
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(3) the number of branching points present in each zone 
(4) the number of dendritic endings in each zone and 
outside the fifteenth zone 
(5) a "branching index" was calculated for each cell as 
the ratio of (4) to (1), i.e., the mean number of 
branches arising from each dendrite emerging from the 
perikaryon. 
The details and limitations of this method are discussed by 
Eayrs (1955) and by Schade and Van Groenigen (1961). In the 
present study, no correction factor was used for the fact that 
the three-dimensional branchings were projected onto a two-dimensional 
field. Thus, the actual density of dendritic branchings is somewhat 
less than that indicated in the graphs. By the same token, the 
total extent of branching is greater in three dimensions than shown 
in the figures. 
c. Statistical Analysis of Data 
The data for the cells of layers 3 and 5 were treated independ¬ 
ently. In each of these layers, the morphological characteristics of 
a "representative neuron" are expressed in terms of the arithmetical 
means of the measurements made on the 15-40 cells studied in the 
tissues of each group of rats. These means were then used to deter¬ 
mine, using Student's t test, the effect of the experimental treatment 




1. General Aspects of Growth and Development 
Twenty-three of the 39 animals treated with steroids at six 
days (from both the myelination and the dendritic development studies) 
died. None of the rats treated at nine and 12 days died. The 
survivors of the steroid-treated groups showed signs of wasting and a 
general retardation of development. The appearance of fur and the 
righting reflex were delayed, the abdominal and gluteal musculature 
were atrophied, and body weight and length were below normal (Figure 2). 
In the three week old rats (Table 1), body weight was reduced to 51.3% 
of normal in the group treated with steroids at six days (Group lb and 
lib). Similar reductions in body weight at three weeks were noted in 
the 9-day treated (Group lie) and 12-day treated animals (Group lid), 
the corresponding percentages being 34.2% and 43.1%, respectively. In 
the six week age group, the rats in Groups lb, lib and lie, although 
exhibiting some catch-up growth, were still well below their control 
littermates in weight (64.4% and 41.0% of controls, respectively). On 
the other hand, the animals in Group lid (injected on day 12) exhibited 
such substantial catch-up growth that at six weeks the difference 
between these animals and their control littermates (90.5% of control) 




Representative littermates, 21 days of age. The rat on the right 
received one injection of 0.02 ml methylprednisolone on postnatal 
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2. Brain Weight 
Brain weights in the steroid-treated rats were less than 
those of the corresponding controls. The reductions in the brain 
weights of the steroid-treated rats are shown in Table 1. 
Brain weight as a percentage of body weight, however, was 
increased in the experimental groups (Table 1). In the three week 
old control group (Groups la and Ila), brain weight comprised 2.94% 
of the total body weight. In comparison, brain weight comprised 
4.9% of total body weight in Groups lb and lib, 5.42% in Group lie, 
and 4.86% in Group IId. In the six week old group, comparable 
percentages were as follows: Controls (Groups la and Ila), 1.03%; 
Groups lb and lib, 1.40%; Group lie, 1.72%; and Group lid, 1.0%. 
These values indicate that in the early stages of development, brain 




a. Fiber Density 
There was a noticeable increase in myelination between the third 
and sixth postnatal weeks in both the treated and control animals. 
Qualitatively, this increase in frequency of myelinated fibers with 
age can be seen by comparison of Figures 3 and 5 (Control, three and 
six weeks, respectively), and of Figures 4 and 6 (Treated, three and 
six weeks, respectively). When compared with their saline treated 
age-matched counterparts, the steroid-treated animals had a signific¬ 
antly lower frequency of myelinated fibers at both time periods. 
This decrease in the treated animals is evident on gross inspection 
of Figures 3 and 4 and of Figures 5 and 6, respectively. 
To quantitate these grossly visible differences, fiber counts 
were made of three randomly selected fields for each rat (Table II). 
At three weeks, 17.0-2.6% of the fibers in the control rats were 
myelinated, compared with 9.6-0.7% in the treated animals (p <.001). 
At six weeks, 31.6*2.0% of the fibers were myelinated in the controls, 
compared with 25.8-1.5% in the treated animals (p < .05) . Thus, the 
frequency of myelinated fibers in the three week old treated rats 
was 56.5% of their control counterparts. However, there appeared 
to be a greater rate of increase in the frequency of myelinated fibers 
between the third and sixth weeks in the treated animals than in the 
controls, so that at six weeks, the frequency of myelinated fibers in 





Section of pyramidal tract of 3 week old control rat (x32,000) 
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FIGURE 4 




Section of pyramidal tract of 6 week old control rat (x32,000) 
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FIGURE 6 
Section of pyramidal tract of 6 week old corticosteroid treated rat (x32,000) 
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TABLE II: FIBER DENSITY 
Rat Group 
Total Number of 
Fibers/Field ± SEM+ 
Number of Myelinated 
Fibers/Field - SEM 
% Myelinated 
Fibers - SEM 
3 week control 373 - 21 69 - 4.6 17.0 - 2.6 
3 week treated 502 - 44 48 - 4.5 9.6 - 0.7* 
6 week control 256 - 50 91 t 15.0 36.1 - 2.0 
6 week treated 344 - 21 88 - 0.5 25.8 1 1.5** 
2 
+ field equals 74.4 ju of pyramidal tract 
* p < .001 
** p < .05 
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(b) Fiber Spectrum 
The frequency of various sized fibers in terms of numbers of 
lamellae in the sheath also showed variations with age and with 
treatment (Table III). There was an increase in mean number of 
lamellae with age (9.51-0.20 at 3 weeks vs. 14.0-0.54 at 6 weeks 
in the controls, and 8.92-0.29 vs. 10.4^0.44 in the treated 
animals), and a decrease in the mean number of lamellae with 
steroid treatment. This decrease with treatment was present in 
the three week old rats and was even more pronounced in the six 
week old group. 
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1 6 WEEKS 
Mean Number of Mean Number of 
Lamellae - SEM Lamellae - SEM 
Control 9.51 - 0.20 
| 




8.92 ± 0.29* 10.4 ± 0.44** 
* p < .05 
** p < .001 
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(c) Relationship between Axon Circumference and Number 
of Lamellae in the Sheath 
The relationship between axon circumference and myelin 
lamellae for each group is shown in Figure 7. Each axon was 
plotted according to its number of lamellae (abscissa) and its 
circumference (ordinate). The slopes of the regression lines 
for each group, calculated by the method of least squares, are 
as follows: 
3 week control 0.75 
3 week treated 1.00 
6 week control 0.42 
6 week treated 0.83 
From this graph, it can be concluded that: (1) the number of 
lamellae in a sheath increases with age for a given axon 
circumference (decrease in slope with age), and (2) the degree 
of myelination, in terms of the number of lamellae for a given 
axon circumference, is retarded in the steroid treated animals. 
When measured by this latter parameter, myelin development in the 
six week old treated animals was actually less than in the three 




AXON CIRCUMFERENCE vs. NUMBER OF LAMELLAE IN SHEATH 
NUMBER OF LAMELLAE IN SHEATH 
Relationship between axon circumference and the number of myelin 
lamellae in the sheaths of pyramidal tract fibers at 3 and 6 weeks 
of age in control and corticosteroid treated rats. Axon circumfer¬ 
ence was measured in map meter units (1 unit = 0.25 ;u) . The slopes 
of the regression line for each group was calculated by the method 
of least squares. 
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4. Dendritic Development 
(a) Basal Dendrites 
The changes in dendritic morphology resulting from cortico¬ 
steroid treatment were qualitatively similar in layers 3 and 5. 
Steroid treatment did not materially alter the number of basal 
dendrites arising from the perikarya in either the three or six 
week old group (Figure 8). Similarly, the branching index was 
not significantly different in the steroid treated group when 
compared with their littermate controls (Figure 8). 
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Mean number of basal dendrites and mean branching index in layer 3 
and layer 5 of parietal cortex of 3 week old and 6 week old rats. 
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(b) Branching Points 
The number of dendrites associated with a given neuron at 
increasing distances from the perikaryon depends on two factors: 
(1) the branching index, and (2) the lengths of the individual 
dendrites and their branches. The influence of these two factors 
on the pattern of distribution of dendrites is illustrated in 
Figures 9-12. In the control group, the peak of branching occurs 
at a distance of between 36 p and 72 p from the center of the 
perikaryon. This relationship was not altered as a result of 
steroid treatment. However, branching continued at distances 
farther from the perikaryon in the controls when compared to the 
treated groups. (This effect is not evident in the branching 
index because the absolute number of total branches and basal 
dendrites are unaffected; the branching index, indeed, does not 
reflect the differences in length of dendrites.) Examination of 
Figures 9 and 10 indicates that, in the three week old group, the 
absolute number of dendrites branching close to the perikaryon 
(- 72 ,u) is enhanced in the rats treated with steroids at 12 days 
in both layers 3 and 5. At six weeks, however, in the control group, 
there is a significantly larger number of dendrites branching farther 
(- 270 p) from the perikaryon than in any of the experimental groups. 
This increase is more pronounced in layer 5 (Figure 22) than in 















Distribution of branching points, layer 3, age 3 weeks. 













































Distribution of branching points, layer 5, age 6 weeks. 

(c) Ending Points 
Figures 13-16 illustrate the mean length of dendrites. In 
the three week group, the peak, in all animal groups, occurs at 
72 - 90 p from the perikaryon in both cortical layers (Figures 13 
and 14). In the six week group, the peaks are not influenced by 
steroid treatment and are 90 p and 108 p, respectively, in layers 
3 and 5. In addition, however, the dendrites in the six week 
group were considerably longer in the controls than in the experi¬ 
mental animals: in the controls, a significant number of dendrites 

































































Figures 17-22 illustrate the mean number of dendrites 
associated with each neuron at increasing distances from the 
perikaryon. These curves show that, up to a radius of 54 u, 
at three weeks, there is a sharp increase in the number of 
dendrites in both cortical layers, due to a predominance of 
branching over ending. Beyond this point, endings predominate, 
and the number of intersections declines (Figures 17 and 18). A 
similar phenomenon is seen in the six week group, in which the 
turning point is reached at 54 ,u in layer 3 and at 72 ,u in layer 
5. Steroid treatment does not appear to influence the location 
of this peak except in the six week group in layer 5, in which 
the peak in the 6- and 9-day steroid treated groups occurs 
earlier (54 .u) than in the control (54 -72 u) or 12-day steroid 















Mean number of dendrites at different distances from perikaryon, 












Mean number of dendrites at different distances from perikaryon, 
















Mean number of dendrites at different distances from perikaryon, 














xMean number of dendrites at different distances from perikaryon, 




Mean number of intersections, branchings, and terminations 
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Pyramidal cells in layer 3 of parietal cortex of rat: 
a) corticosteroid treated, age 3 weeks; b) control, age 3 weeks; 











Pyramidal cells in layer 5 of parietal cortex of rat: 
a) corticosteroid treated, age 3 weeks; b) control, age 3 weeks 








In this study, an experimental model was used to evaluate the 
effects of corticosteroid administration on structural changes in 
brain development, specifically those involving myelination and 
dendrite formation. Significant alterations in both myelin develop¬ 
ment and dendritic proliferation were found in steroid-treated animals. 
Whether it is valid to extrapolate the results reported here for 
rats to the human brain is an important question. The implications of 
the changes in myelination and dendrite formation described above are 
probably best appreciated by first discussing the rationale behind 
some aspects of the experimental procedure. In particular, the following 
points need elaboration: (1) choice of experimental animal; (2) time 
of injection; (3) choice of drug; (4) determination of suitable para¬ 
meters for evaluation of structural changes in the brain; and (5) select¬ 
ion of areas in which to evaluate these parameters. 
First, the use of rats in this experiment is supported by 
comparative studies of brain development. Such studies (Donaldson, 1908; 
Sugita, 1917a; Sugita, 1917b; Sugita, 1918a; Sugita, 1918b; Smith, 
1934; Dobbing, 1968a) have indicated that increases in both brain 
weight and cortical thickness follow a triphasic curve in both rats and 
humans, although the rate of growth in rats is much more rapid. Because 
of this similarity in growth pattern, but difference in growth rate, 
the effect of steroid treatment on rats could be studied in a shorter 
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time than would have been possible in an animal with a slower develop¬ 
mental period. Further support for the use of rats in this study was 
obtained post facto by the observation that the steroid response of 
the experimental animals was similar in many ways to that observed 
in humans. For instance, the decrease in brain and body size and the 
distribution of muscle atrophy found in the steroid treated rats were 
similar to that which has been reported for humans (Ritter, 1967). 
Second, rats were not injected until six days postnatally because 
the cerebral cortex of the rat at the time of birth is somewhat less 
developed than the human cortex at birth. Specifically, the human 
brain at birth is similar in development to that of a rat of approximately 
five days of age (Smith, 1934, Dobbing, 1972). 
Third, methylprednisolone was employed in this study because of 
its similarity in potency to triamcinolone, which was administered 
chronically to the infant described in the case report. Furthermore, 
the dosage per gram of body weight chosen was comparable to that used 
in humans on chronic steroid therapy and, in fact, was less than the 
total dose administered to the infant over a seven month period. 
Fourth, myelination and dendritic development were chosen for 
evaluation in this study because it has been suggested that interference 
with these processes during the "vulnerable period"in mammals (Dobbing, 
1968b) which, in humans, includes the last trimester of gestation and 
first 18-24 postnatal months, may lead to serious motor, intellectual. 
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and behavioral impairment. The essentials of this theory will be 
discussed in greater detail below. Furthermore, the neurochemical, 
electrophysiological, and behavioral studies by Howard (1965, 1968a), 
Schapiro (1968) and Salas and Schapiro (1970), strongly suggested an 
interference with these processes. 
Finally, to study myelination, the pyramidal tracts were selected 
for two reasons. Since myelination of the central nervous system 
occurs first in the motor areas (Jacobson, 1963), the corticospinal 
system would be expected to reveal any alterations in the normal 
myelination process. Technically, the pyramidal tracts are easily 
identified and localized so that comparable sections from all animals 
could be readily obtained. For dendritic development, the parietal 
cortex was selected as it has been suggested (Sholl, 1953; Sholl and 
Uttley, 1953) that the discriminatory functions mediated by the 
parietal cerebral cortex are dependent on dendritic organization to 
provide the necessary neuronal connections. In previous studies on the 
selectivity of the Golgi-Cox method (Eayrs, 1955), it has been shown 
that only two groups of cells appear constantly in all sections, namely 
layers 3c and layer 5b. Therefore, in this study, neurons were chosen 
for analysis from these two groups. 
In most mammals, structural, biochemical, and functional maturation 
of the brain is incomplete at birth (Bass, Netsky § Young, 1969a; Bass, 
Netsky 8 Young, 1969b and others). Comparative studies of humans and 
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rats (Donaldson, 1908; Sugita, 1917a; Sugita, 1917b; Sugita, 1918a; 
Sugita, 1918b; Smith, 1934) have indicated that increases in both 
brain weight and cortical thickness follow a triphasic curve, 
characterized by two periods of rapid growth interrupted by a relatively 
quiescent period. The rat is a particularly suitable experimental 
model for studying the development of the cerebral cortex, as its brain 
is relatively undifferentiated at birth. The somesthetic cortex has 
been extensively studied by neuroanatomists (Lorente de No, 1949; Eayrs, 
1959 and others), and neurochemists (Brante, 1949; Folch-pi, 1955; 
Greanley, 1961; Sperry, 1962; Bass and Hess, 1969; Howard, Granoff 
5 Bujnovszky, 1969; Banik and Davison, 1971; Jungalwala and Dawson, 
1971). By correlating quantitative neurochemical data with histological 
studies, the events in normal cortical development have been defined 
(Flexner, 1952). 
Grossly, the increase in cortical dimensions is largely due to 
the increase in cell size, the growth of dendrites, and myelin deposition 
(Schade and van Groenigen, 1961; Davison and Dobbing, 1966; Caley, 1971). 
Between the ages of 10 and 50 days, the following changes have been 
demonstrated: (1) continuous migration of small cells, reflected by 
increases in DNA and RNA; (2) neuronal differentiation characterized 
by axodendritic proliferation and synaptic formation, reflected in 
increased ganglioside sialic acid, most marked between 15 and 25 days 
of age; and (3) accumulation of myelin lipids (total lipid, cerebro- 
sides, cholesterol, and proteolipid protein) between 10-30 days, succeeded 
by formation of myelin lamellae during the period between 30-40 days of 
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age (Bass and Hess, 1967; Bass, Hess § Pope, 1968; Bass, Netsky 5 
Young, 1969b). This data is consistent with other quantitative 
histological studies on the postnatal development of the rat which 
have demonstrated that prior to six days of age, very few dendrites 
appear, but by twelve days of age, the mean number of dendrites 
arising from the perikaryon has reached the adult level. Subsequent 
development results in an increase in the extent of the dendritic 
field, the most rapid increment occurring between eighteen and twenty- 
four days (Eayrs and Goodhead, 1959). Corresponding studies in the 
human (Schade and von Gorenigen, 1961) have demonstrated that differ¬ 
entiation of dendritic ramifications has just commenced at birth. By 
three months, a marked increase in length, diameter, and branching of 
cell processes has occurred. By six months, there is a striking 
growth in the dendritic plexus. Between six and fifteen months, the 
dendrites do not increase in number although they increase in length 
and size. By the age of two years, neuronal differentiation is essent 
ially complete and, although there is some growth after two years, the 
rate is markedly decreased. 
Myelination in the rat is not initiated until after birth, with 
a particularly rapid phase from ten to twenty-eight days (Davison and 
Dobbing, 1966; Samorajski and Friede, 1968; Davison, 1970; Davison, 
1972). The process continues at a slower rate for about 180 days post 
part urn. In the human, the process commences in the third trimester 




Thus, both myelination and dendrite formation are relatively 
late developmental events in both the rat and the human. 
It has been postulated that insults to developing organ systems 
during critical stages of development may have irreversible long-term 
sequelae (Dobbing, 1968b; Davison and Dobbing, 1968; Dobbing, 1970a; 
Dobbing, 1970b; Dobbing and Sands, 1970; Winick, 1970a; Dobbing and 
Sands, 1972; Smart, 1971). In particular, the brain is likely to be 
most vulnerable to permanent alterations during the period of the "brain 
growth spurt", which, in mammals, is a late developmental event. This 
brain-growth spurt is characterized by two parts. The initial period, 
largely prenatal in humans (25 weeks of gestation) and partly postnatal 
in rats (two days) is concerned with neuroblast division. This period 
is followed by growth in length and numbers of cell processes (dendrites), 
establishment of synapses, and myelination (Dobbing, 1970a). Thus glial 
cells, which elaborate myelin (Bunge, 1968), begin their mitotic growth 
spurt after cessation of the neuronal growth spurt. 
Growth impairment induced by injurious conditions (e.g., malnutrition, 
anoxia, x-irradiation, hypothyroidism, corticosteroids) does not alter the 
timing of the growth spurt in the brain (Dobbing, 1970a). Thus, rather 
than a true temporal retardation in the brain growth spurt, brain injury 
is reflected in a decrease in the extent of the process which nevertheless 
occurs at a set, preordained time. Therefore, the brain is an organ with 
only one opportunity to accomplish its important developmental events. 
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Once this opportunity is lost, it probably cannot be recovered. 
Furthermore, since the pattern of brain development is constant in 
mammalian species, the hypothesis of vulnerable periods can be experi¬ 
mentally tested in animals, assuming species differences in the timing 
of birth are taken into account (Dobbing, 1972). 
In the present study, the brains of the steroid treated animals 
were significantly smaller than those of the controls at three weeks 
of age. However, the brain appeared to be relatively spared, as 
reflected by the larger brainrbody ratio in the treated animals. At 
six weeks, this sparing effect appeared to be lost: although the brain: 
body ratio was significantly larger in the rats treated at six and nine 
days, the body weight was greater for the same brain weight in younger 
controls, and hence reflects a true microcephaly. This effect was not 
observed in the rats treated at 12 days which, in fact, did appear to 
catch up to their control littermates. 
■v 
The myelination process in the steroid-treated animals in the 
present study was found to be considerably retarded as demonstrated by: 
(1) the decrease in the frequency of myelinated fibers per unit area; 
(2) the decrease in the mean number of lamellae per sheath, which was 
more pronounced at six weeks; and (3) the increase in the slope of 
the curve plotting the number of lamellae (x) vs. the axon circumference 
(y). It is interesting to note that with respect to this last index, 
the six week old treated animals were actually less developed than the 





per given area was larger. Similarly, the six week old treated group 
also showed a marked resemblance to the three week old control group 
with respect to distribution of fibers. This would seem to indicate 
that although the percentage of myelinated fibers in the steroid 
treated group was increasing, the fibers were immature. 
This study also demonstrated significant effects on dendritic 
development. [The values for the controls are consistent with those 
reported earlier by Eayrs (1955)]. It was found that steroids affect 
the ability of dendrites to proliferate, elongate, and branch at their 
terminal arborizations. This impairment is reflected in the decrease 
in the number of dendrites and their branches at distances farther 
from the perikaryon. This effect was noticeable in both layer 3 and 
layer 5 of the parietal cortex. An exception to this trend was shown 
by rats treated at twelve days and sacrificed at three weeks of age, 
which demonstrated significantly increased dendritic development in 
layers 3 and 5. By the age of six weeks, this advantage had been lost. 
In this regard, it is interesting to note that although the mechanism 
of action is different (Balazs and Cotterrell, 1972; Richter, 1972), 
a similar effect has been observed in synaptogenesis in hyperthyroid 
rats. Such animals have been found to exhibit an initial acceleration 
of cerebellar synapse formation but an ultimate reduction in the total 
number of synapses (Nicholson and Altman, 1972). It appears that the 
consequences of an insult are complex, and may depend not only upon 




These structural changes in the pattern of myelination and 
dendritic development due to treatment with steroids during the neo¬ 
natal period may explain some of the neurochemical, electrophysiological, 
and behavioral changes described by others. The retardation in 
swimming ability and delayed appearance of evoked cortical potentials 
described by Schapiro is consistent with a decrease in myelinated fibers. 
The "brain-damage behavior syndrome" in humans has been characterized 
by decreased motor coordination and emotional lability (Birch, 1964). 
More recently, young children with profound mental deficiency have been 
observed to have abnormalities of cortical dendritic development as the 
only or the major pathologic finding (Huttenlocher, 1970; Huttenlocher, 
in press). Motor retardation, microcephaly, and delayed developmental 
milestones were observed in the infant reported in this case report. 
Thus the structural data reported here are consistent with known neuro¬ 
chemical and functional changes, and suggest that brain damage syndromes 
might be caused by interference with the processes of neuron maturation 
which have their maximal rate during the brain growth spurt. 
The results of the present study leave the mechanism of action 
of steroids on the central nervous system open to speculation. The 
derangements in gross brain size, myelination, and dendritic prolifer¬ 
ation may be a direct effect of the steroids on the brain. On the other 
hand, the defects in central nervous system development documented here 
could be due to a secondary effect of the steroids on other organ systems* 
such as functional malnutrition due to defective intestinal absorption. 
Still a third possibility is that the steroids exert their effect via 
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the functional thymectomy they produce and that the central nervous 
system changes are part of the spectrum of defects known as the 
"runting syndrome". The wasting syndrome that occurs following 
neonatal corticosteroid administration is quite similar to that observed 
in a variety of animal species following early thymectomy (Azar, 1964; 
Schlesinger and Mark, 1964; Reed and Jutila, 1965; Schapiro, 1965; 
Schapiro and Huppert, 1967). In addition, Winick and Coscia (1968) 
reported studies implicating destruction of the thymus as the primary 
event in cortisone-induced runting. Indeed, at the time of sacrifice, 
the thymuses in our treated animals appeared markedly atrophic. 
Regardless of its mechanism of action, neonatal corticosteroid 
treatment has been demonstrated to have an adverse effect in the rat 
on the development of the structural components of the central nervous 
system, particularly with regard to myelination and dendritic develop¬ 
ment. Such changes in morphology provide an explanation for formerly 
observed neurochemical, functional, and behavioral alterations in the 




1. A case report was presented in which intensive corticosteroid 
treatment during infancy was associated with marked developmental 
retardation, including microcephaly, motor impairment, muscle 
atrophy, and general wasting. 
2. A model system using rats was established to evaluate the effect of 
steroids on certain structural parameters of brain development, 
in particular, myelination and dendritic development. 
3. Treatment of Sprague-Dawley rats with 0.02 ml of methyIprednisolone 
(equivalent to a dose of 0.06 mg/gm body weight) on the sixth 
postnatal day had the following effects: 
a) significant decrease in overall brain weight, which was less 
than the decrease in total body weight; 
b) decrease in frequency of myelinated fibers, which seemed to 
improve with age; 
c) decrease in mean number of lamellae, which showed only slight 
improvement with age; 
d) decrease in number of lamellae for a given axon circumference, 
which did not improve with age; 
e) decrease in number of dendrites intersecting, branching, and 
ending at distances farther from the perikaryon, which did 
not improve with age. 
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4, These alterations in myelination and dendritic development are 
consistent with previous studies by other investigators, 
describing changes in neurochemical, physiological, and 
behavioral parameters, and provide a possible explanation for 
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